Biohaven (BHVN) CEO Vlad Coric reports RSU vesting and share withholding

Rhea-AI Filing Summary

Biohaven Ltd. Chief Executive Officer and director Vlad Coric reported routine equity compensation activity. On January 5, 2026, 14,250 restricted share units vested and were converted into 14,250 common shares at $0 per share. On the same date, 7,430 common shares were withheld by Biohaven at $9.93 per share to cover tax obligations, and no shares were sold into the market.

Following these transactions, Coric directly holds 1,803,968 common shares and 28,500 restricted share units. Additional common shares are held indirectly through a family trust, a marital trust and a 401(k) plan. The family and marital trust positions are for the benefit of family members other than Coric, and he disclaims beneficial ownership of those securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coric Vlad

(Last) (First) (Middle)

C/O BIOHAVEN LTD.

215 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Biohaven Ltd. [ BHVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/05/2026		M		14,250	A	$0	1,811,398	D
Common Shares	01/05/2026		F		7,430(1)	D	$9.93	1,803,968	D
Common Shares								1,195,275	I	By: The Vlad Coric Family Trust(2)
Common Shares								740,546	I	By: The Vladimir Coric Marital Trust(2)
Common Shares								109,565	I	By: 401(K) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit Award	(3)	01/05/2026		M			14,250	(4)	(5)	Common Shares	14,250	$0(3)	28,500	D

Explanation of Responses:

1. No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.

2. These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

3. Each restricted share unit represents the contingent right to receive one common share of the Issuer.

4. The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.

5. Not applicable.

Remarks:

	/s/ George Clark, Attorney-in-Fact	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Biohaven (BHVN) report for CEO Vlad Coric?

The filing shows that on January 5, 2026, CEO Vlad Coric had 14,250 restricted share units vest into common shares and 7,430 common shares withheld by Biohaven to satisfy tax obligations related to that vesting.

Did Vlad Coric sell any Biohaven (BHVN) shares in this transaction?

No shares were sold. The filing states that the 7,430 common shares were withheld by Biohaven solely to cover tax withholding requirements in connection with the vesting of restricted share units.

How many Biohaven (BHVN) shares does Vlad Coric own after this Form 4?

After the reported transactions, Vlad Coric directly owns 1,803,968 common shares of Biohaven and holds 28,500 restricted share units, each representing the right to receive one common share.

What are the terms of Vlad Coric’s Biohaven restricted share unit grant?

The filing explains that Coric was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to his continued service with Biohaven on each vesting date.

How are indirect holdings in Biohaven (BHVN) reported for Vlad Coric?

The filing lists indirect common share holdings through The Vlad Coric Family Trust, The Vladimir Coric Marital Trust, and a 401(k) plan. The family and marital trust shares are held for the benefit of family members (excluding Coric), and he disclaims beneficial ownership of those securities.

What does the tax withholding transaction mean in the Biohaven (BHVN) filing?

The F transaction code and footnote explain that 7,430 common shares were withheld by Biohaven at $9.93 per share to pay taxes triggered by RSU vesting, rather than being sold on the open market.